Compared with Nov 4, 2026
PEPTIDEBENCHMARK MARKET INTELLIGENCE
November 2026
Peptide Price Index
Data through Nov 11, 2026Baseline = 100 on Jun 3, 2026
Compared with Oct 14, 2026
Current lanes with at least three vendors
3,096 vendor observations
Most tracked medians moved lower
Movement is based on each peptide’s median effective price per milligram, with ±0.5% treated as approximately flat.
The largest changes in median effective $/mg
These are market-lane medians—not a single vendor’s promotion or a claim about completed transactions.
Largest decreases
01Vilon9 vendors · $2.19/mg-11.6%02Glutathione78 vendors · $0.0456/mg-8.8%035-Amino-1MQ68 vendors · $2.00/mg-8.8%04Selank103 vendors · $4.00/mg-8.6%05AHK-CU26 vendors · $0.4499/mg-7.5%06FOXO4-DRI24 vendors · $11.25/mg-7.4%07MOTS-c123 vendors · $3.50/mg-7.0%08Vesugen12 vendors · $2.50/mg-6.6%Largest increases
01Hexarelin18 vendors · $9.00/mg+12.5%02hGH Frag 176-1916 vendors · $6.16/mg+2.7%03TB-500 Fragment 17-238 vendors · $4.50/mg+2.0%04MGF6 vendors · $13.35/mg+1.1%05Mazdutide11 vendors · $8.96/mg+0.5%06Oxytocin43 vendors · $5.78/mg+0.5%07Survodutide16 vendors · $8.55/mg+0.3%08LL-3742 vendors · $9.00/mg+0.1%Median prices at a new tracked low
Requires at least 14 qualifying observations and three current vendors. Gaps are not interpolated.
The absence of a new low is itself retained with this edition; PB does not force a headline when the data does not support one.
The most broadly priced peptide lanes
Vendor and offer counts help readers distinguish broad market signals from thinner listings.
| Peptide | Vendors | Offers | Median effective / mg | Current low / mg | 28 day |
|---|---|---|---|---|---|
| BPC-157 ↗ | 128 | 251 | $4.80 | $0.7470 | -2.0% |
| GHK-Cu ↗ | 124 | 258 | $0.5711 | $0.1375 | -4.7% |
| MOTS-c ↗ | 123 | 282 | $3.50 | $0.7470 | -7.0% |
| Tesamorelin ↗ | 108 | 202 | $6.30 | $2.03 | -2.8% |
| Ipamorelin ↗ | 108 | 155 | $5.22 | $0.7920 | -2.9% |
| NAD+ ↗ | 107 | 211 | $0.1020 | $0.0325 | -5.6% |
| Semax ↗ | 106 | 149 | $3.96 | $0.2400 | -0.5% |
| KPV ↗ | 106 | 133 | $4.30 | $0.7470 | -3.3% |
| Selank ↗ | 103 | 137 | $4.00 | $0.8190 | -8.6% |
| PT-141 ↗ | 100 | 121 | $4.00 | $0.7470 | -0.0% |
| DSIP ↗ | 99 | 137 | $5.33 | $0.8640 | -1.2% |
| TB-500 ↗ | 97 | 159 | $6.21 | $1.71 | -0.5% |
What this report measures—and what it does not
Every edition carries its construction and coverage snapshot so later citations are interpreted against the data available at publication.
Tracked listing prices
Median effective USD per milligram across exact-comparability offers, using the discount rules recorded with each pricing snapshot.
Fixed-cohort index
Equal-weighted fixed cohort. Each eligible peptide is normalized to 100 at its first observation; daily index values average available normalized medians and require at least 70% cohort coverage.
Coverage limits
This is a tracked-listing index, not a transaction-price index. Vendor mix, availability, quantities, discounts, and catalog coverage can change over time.
PeptideBenchmark. “November 2026 Peptide Price Index Report.” Data through Nov 11, 2026. https://peptidebenchmark.com/prices/reports/2026-11/